妊娠期促甲状腺激素和游离甲状腺素参考区间建议与妊娠期甲状腺功能异常患病率:当前诊断方法的量化
该研究纳入甲状腺与妊娠联盟的52 496名参与者,量化当前指南推荐的妊娠期促甲状腺激素(TSH)和游离甲状腺素(FT4)参考区间(RIs)替代诊断方法的诊断后果。与妊娠期特异性RIs相比,替代方法检测有治疗指征或考虑治疗的孕妇的敏感性低(0.63-0.82)、错误发现率高(0.11-0.35)。结论认为替代方法导致显著过度诊断和诊断不足,需探索更多策略优化妊娠期甲状腺功能异常的识别。
要点
- 与妊娠期特异性参考区间相比,替代方法检测治疗指征的敏感性为0.63-0.82,错误发现率为0.11-0.35。
- 固定上限法、减法法和非妊娠参考区间法在孕早期检测治疗指征的敏感性和错误发现率相似(0.77-0.11 vs 0.74-0.16 vs 0.60-0.11)。
- 检测显性甲状腺功能减退、孤立性低甲状腺素血症和(亚)临床甲状腺功能亢进的诊断性能主要因FT4参考区间方法而异,而检测亚临床甲状腺功能减退的诊断性能因TSH参考区间方法而异。
核心结论
- 与人群和妊娠期特异性参考区间相比,妊娠期TSH和FT4参考区间的替代定义方法导致相当程度的过度诊断和诊断不足。
- 需要探索更多策略以优化妊娠期甲状腺功能异常的识别。
研究设计与样本
- 研究纳入甲状腺与妊娠联盟的队列,共52 496名参与者来自18个队列。
- 采用不同方法定义参考区间:TSH固定上限4.0 mU/L(固定上限法)、TSH上限固定减去0.5 mU/L(减法法)以及使用非妊娠参考区间。
- 结局指标为根据国际指南有左甲状腺素治疗指征或考虑治疗的女性的敏感性和错误发现率(FDR)。
主要发现
- 与妊娠期特异性参考区间相比,替代方法检测有治疗指征或考虑治疗的孕妇的敏感性低(0.63-0.82)、错误发现率高(0.11-0.35)。
- 孕早期检测治疗指征的敏感性和错误发现率在固定上限法、减法法和非妊娠法之间相似(0.77-0.11 vs 0.74-0.16 vs 0.60-0.11)。
- 检测显性甲状腺功能减退、孤立性低甲状腺素血症和(亚)临床甲状腺功能亢进的诊断性能主要因FT4参考区间方法而异。
- 检测亚临床甲状腺功能减退的诊断性能因所应用的TSH参考区间方法而异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Guidelines recommend use of population- and trimester-specific thyroid-stimulating hormone (TSH) and free thyroxine (FT4) reference intervals (RIs) in pregnancy. Since these are often unavailable, clinicians frequently rely on alternative diagnostic strategies. We sought to quantify the diagnostic consequences of current recommendations. METHODS: We included cohorts participating in the Consortium on Thyroid and Pregnancy. Different approaches were used to define RIs: a TSH fixed upper limit of 4.0 mU/L (fixed limit approach), a fixed subtraction from the upper limit for TSH of 0.5 mU/L (subtraction approach) and using nonpregnancy RIs. Outcome measures were sensitivity and false discovery rate (FDR) of women for whom levothyroxine treatment was indicated and those for whom treatment would be considered according to international guidelines. RESULTS: The study population comprised 52 496 participants from 18 cohorts. Compared with the use of trimester-specific RIs, alternative approaches had a low sensitivity (0.63-0.82) and high FDR (0.11-0.35) to detect women with a treatment indication or consideration. Sensitivity and FDR to detect a treatment indication in the first trimester were similar between the fixed limit, subtraction, and nonpregnancy approach (0.77-0.11 vs 0.74-0.16 vs 0.60-0.11). The diagnostic performance to detect overt hypothyroidism, isolated hypothyroxinemia, and (sub)clinical hyperthyroidism mainly varied between FT4 RI approaches, while the diagnostic performance to detect subclinical hypothyroidism varied between the applied TSH RI approaches. CONCLUSION: Alternative approaches to define RIs for TSH and FT4 in pregnancy result in considerable overdiagnosis and underdiagnosis compared with population- and trimester-specific RIs. Additional strategies need to be explored to optimize identification of thyroid dysfunction during pregnancy.
引用
- Osinga JAJ, Derakhshan A, Feldt-Rasmussen U, et al. TSH and FT4 Reference Interval Recommendations and Prevalence of Gestational Thyroid Dysfunction: Quantification of Current Diagnostic Approaches. J Clin Endocrinol Metab. 2024. PMID: 37740543. doi:10.1210/clinem/dgad564
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。